About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Leukemia Clinical Trials in Michigan | 27 Studies

Clinical Trials LeukemiaMichigan

Leukemia Clinical Trials in Michigan

Find 27 clinical trials for leukemia near Michigan. Connect with research centers in your area.

All Leukemia trials nationwide All trials in Michigan

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1-20 of 27 trials

TerminatedObatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or LeukemiaThis phase I trial is studying the side effects and best dose of obatoclax mesylate when given together with vincristine sulfate, doxorubicin hydrochloride, and dexrazoxane…NCT00933985·Birmingham, Alabama and 19 others

Page 1 of 2Next

Leukemia Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

No longer availableUmbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseRATIONALE: Giving low doses of chemotherapy and total-body irradiation before a donor umbilical cord blood stem cell transplant helps stop the growth of cancer or abnormal cells.NCT00423826·Detroit, Michigan

CompletedS9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic CancerRATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors learn more about diagnosing cancer and how…NCT00919425·Fort Smith, Arkansas and 291 others

CompletedMK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or LeukemiaThis phase I trial is studying the side effects, best way to give, and best dose of Akt inhibitor MK2206 (MK2206) in treating patients with recurrent or refractory solid tumors or…NCT01231919·Birmingham, Alabama and 24 others

Active not recruitingHLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD ProphylaxisThe goal of this clinical trial is to determine the effectiveness of Reduced Dose Post-Transplant Cyclophosphamide (PTCy) in patients with hematologic malignancies after receiving…NCT06001385·Phoenix, Arizona and 31 others

TerminatedMycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)RATIONALE: Mycophenolate mofetil added to immunosuppressive treatment regimens may be effective in treating newly diagnosed chronic graft-versus-host disease caused by stem cell…NCT00089141·Duarte, California and 15 others

CompletedAprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell TransplantRATIONALE: Antiemetic drugs, such as aprepitant, granisetron, and dexamethasone, may help lessen or prevent nausea and vomiting in patients treated with chemotherapy.NCT00293384·Detroit, Michigan

CompletedStandard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for CancerRATIONALE: Telephone counseling by trained counselors may enhance the well-being and quality of life of patients who have undergone stem cell transplantation for cancer.NCT00049465·Stanford, California and 8 others

Active not recruitingA First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic MalignanciesThe goal of this clinical trial is to determine the safety and feasibility of allogeneic transplantation with bone marrow from a deceased donor in patients with acute and chronic…NCT05589896·Duarte, California and 8 others

CompletedCollecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With CancerThis study is collecting and storing malignant, borderline malignant neoplasms, and related biological samples from young patients with cancer.NCT00898079·Birmingham, Alabama and 191 others

CompletedS9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic CancersRATIONALE: Studying samples of bone marrow and blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify…NCT00996047·Mobile, Alabama and 279 others

CompletedAmerican Ginseng in Treating Patients With Fatigue Caused by CancerRATIONALE: American ginseng may reduce fatigue in patients with cancer.NCT00719563·Scottsdale, Arizona and 325 others

TerminatedDasatinib for Immune Modulation After Donor Stem Cell Transplant for Hematologic MalignanciesThis study uses a drug called dasatinib to produce an anti-cancer effect called large granular lymphocyte cellular expansion.NCT01643603·Detroit, Michigan

Active not recruitingHLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation CyclophosphamideThis is a prospective, multi-center, Phase II study of hematopoietic cell transplantation (HCT) using human leukocyte antigen (HLA)-mismatched unrelated donors (MMUD) for…NCT04904588·Duarte, California and 38 others

CompletedA Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic MalignanciesThe purpose of this study is to determine the maximum tolerated dose (MTD) of TAK-901 in subjects with advanced hematological malignancies, and to further assess the safety and…NCT00807677·Ann Arbor, Michigan

CompletedINCB18424 in Treating Young Patients With Relapsed or Refractory Solid Tumor, Leukemia, or Myeloproliferative DiseaseRATIONALE: INCB18424 (Ruxolitinib) may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.NCT01164163·Birmingham, Alabama and 23 others

CompletedCyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer TreatmentRATIONALE: Cyproheptadine and megestrol may improve appetite and help prevent weight loss in children with cancer.NCT00066248·Oakland, California and 42 others

CompletedPersonalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical TrialRATIONALE: Providing information that is tailored to answer patients' questions about clinical trials may help patients with cancer decide to enroll in a clinical trial.NCT00750009·Detroit, Michigan and 3 others

CompletedNovel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)Acute Graft-versus-Host-Disease (GVHD) is an important cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT).NCT02208037·Duarte, California and 29 others

CompletedVorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological MalignanciesThis pilot phase II trial studies how well giving vorinostat, tacrolimus, and methotrexate works in preventing graft-versus-host disease (GVHD) after stem cell transplant in…NCT01789255·Ann Arbor, Michigan

Other Conditions in Michigan

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Lymphoma